|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4178 | |
| A61K 31/194 | |||
| A61K 31/198 | |||
| A61K 45/06 | |||
| A61K 31/395 | |||
| A61P 1/16 | |||
| A61P 1/04 | |||
| A61P 29/00 |
| (11) | Number of the document | 3256124 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15882259.3 |
| Date of filing the European patent application | 2015-09-22 | |
| (97) | Date of publication of the European application | 2017-12-20 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/051467 |
| Date | 2015-09-22 |
| (87) | Number | WO 2016/130179 |
| Date | 2016-08-18 |
| (30) | Number | Date | Country code |
| 201562114304 P | 2015-02-10 | US |
| (72) |
LEFEBVRE, Eric, US
|
| (73) |
Tobira Therapeutics, Inc.,
701 Gateway Boulevard, Suite 300, South San Francisco CA 94080,
US
|
| (54) | COMPOSITION COMPRISING CENICRIVIROC AND FUMARIC ACID FOR USE IN THE TREATMENT OF ACUTE LIVER INJURY OR PERITONITIS |
| COMPOSITION COMPRISING CENICRIVIROC AND FUMARIC ACID FOR USE IN THE TREATMENT OF ACUTE LIVER INJURY OR PERITONITIS |